Exhibit 10.1
MYMETICS CORPORATON
Route de la Corniche 4
CH-1066 Epalinges, Switzerland
July 30, 2010
Mr. Ernst Luebke
39, Route dArzier
1273 Arzier, Switzerland
Dear Ernst:
This letter is to set forth the agreement between Mymetics Corporation and its subsidiaries
(Mymetics) and you concerning the termination of your employment with Mymetics (this
Agreement).
1. Date of Termination.
Your employment as CFO of Mymetics is terminated effective July 30,
2010 (Termination Date).
2. Board Resignation.
You agree that effective December 31, 2010 you will resign from the
various Mymetics Boards of Directors on which you serve as a director.
3. Separation Pay.
Mymetics agrees to enter into a Consulting Agreement commencing August 1,
2010 in the form attached as
Exhibit
A
to this Agreement pursuant to which you will
have the title of Senior Advisor to the President. Mymetics will pay you CHF 25,000 per month
through December 31, 2010 for such consulting services. Mymetics will also pay to you all of your
reasonable business expenses incurred on behalf of Mymetics through the date of this Agreement.
4. Return of Mymetics Property.
You agree to return all property and confidential
information of Mymetics that is in your possession upon the date of this Agreement, including any
computers, software, keys, access cards, etc.
5. Stock Options.
You will receive an option under Mymetics 2009 Stock Incentive Plan to
acquire 250,000 shares of Mymetics common stock. The option shall be fully vested as of the date of
grant which was December 3, 2009.
6. Cessation of Contacts; Certain Relationships.
You agree that, except as requested by the
President of Mymetics, you will not have any further business contacts nor interfere in any way
with prospective investors, customers, current or future merger partners, joint venture or
strategic partners, lenders, banks, investors or acquisition targets of Mymetics, of which you have
knowledge as of the date of your execution of this Agreement.
Mr. Ernst Luebke
July 30, 2010
Page 2
7. Condition Precedent
. All obligations of both parties under this Agreement are specifically
conditioned upon each partys compliance with their respective obligations herein.
8. Confidentiality
. Because, as part of your employment, you had access to information of a
nature not generally disclosed to the public, you will be expected, and hereby agree, to keep
confidential and not disclose to anyone, for a period of five years from the date of this
Agreement, the business, proprietary, and trade secret information in your possession, as well as
the personal, confidential, or otherwise proprietary information regarding Mymeticss employees,
personnel practices and related matters. This obligation is understood to be in addition to any
agreements you may have signed with Mymetics concerning non-competition, non-disclosure, secrecy,
security, new products and services, ideas, inventions, and confidential data, which agreements
will remain in full force and effect. You agree that you will not take, copy, use or distribute in
any form or manner documents or information which Mymetics reasonably deems proprietary, including,
but not limited to, lists of customers or potential customers, financial information, business and
strategic plans, and codes, access codes, and other similar materials or information. Unless as
otherwise required by law, or agreed upon, Mymetics and you agree not to disclose the terms of this
Agreement to any person or entity other than officers, directors and employees of Mymetics or legal
counsel, consultants and other professionals retained by Mymetics or you who need to know such
information in connection with such employment or engagement and who have agreed to preserve the
confidentiality of such information.
9. Non-Disparagement.
You agree that you will not make any statements that disparage
Mymetics, including its successors, assigns, parents, subsidiaries, divisions, affiliates,
officers, directors, employees, agents and representatives, with respect to any matter whatsoever.
Mymetics and its successors, assigns, officers, directors, employees, agents and attorneys agree
that they will not make any statements that disparage you with respect to any matter whatsoever.
If inquiry is made regarding the reasons for your departure by any third party, the parties agree
hat said third party will be informed that you left to
prepare for your retirement and that you continued to serve as Advisor to the President until the
end of 2010.
10. Release.
a.
In connection with the benefits being provided to you under this Agreement, certain of
which, absent this Agreement, you would not be entitled to receive, you, on behalf of yourself,
your heirs, estate, executors, administrators, successors and assigns, hereby irrevocably and
unconditionally release, acquit and forever discharge Mymetics, its former, current and future
directors, officers, and employees acting in their official capacities, and all their successors
and assigns, and all agents of Mymetics (all of which are hereinafter collectively referred to in
this Section as Mymetics), from any and all claims, demands, losses, liabilities, and causes of
action of any type (Claims) arising or accruing on or before the date this Agreement is
executed, as a result of or because of any act, omission, or failure to act by Mymetics,
including but not limited to those directly related to or relating in any way to your employment
by, investment in, association with, and termination of employment with Mymetics (hereinafter
collectively referred to as Claims). This release includes, but is not limited to Claims arising
under the Age Discrimination in Employment Act, the Older Workers Benefit
Mr. Ernst Luebke
July 30, 2010
Page 3
Protection Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the
Civil Rights Act of 1866, the Civil Rights Act of 1991, the Federal Equal Pay Act, the Family and
Medical Leave Act, the Immigration Reform and Control Act, the Uniformed Services Employment and
Reemployment Rights Act, the Employee Retirement Income Security Act, the Workers Adjustment and
Retraining Notification Act, the Fair Labor Standards Act, the National Labor Relations Act, and
under any other federal, state, and local laws or regulations in the United States or Switzerland,
and any Claims under common law, including but not limited to any claims for wrongful discharge,
breach of contract, and any and all tort claims.
THIS IS A GENERAL RELEASE
, with the sole
exception of the obligations of Mymetics to you under this Agreement.
b.
Mymetics and its successors, assigns, officers, directors and employees acting in their
official capacities and their successors and assigns, and all agents of Mymetics do hereby agree to
forever release you, your heirs, estate, executors, administrators, successors and assigns
(hereinafter collectively referred to as your Releasees), from any and all Claims of any kind
whatsoever, which Mymetics ever had, now has or may have against you and your Releasees or any of
them, in law or equity, whether known or unknown, for, upon, or by reason of, any matter
whatsoever, including any act, omission, or failure to act by you, occurring up to the date this
Release is signed by Mymetics, including without limitation claims directly related to or relating
in any way to your employment by, association with, and termination of employment with Mymetics .
THIS IS A GENERAL RELEASE
, with the sole exception of Claims to enforce Mymeticss rights under, or
with respect to, this Agreement.
11. Noncompete and Nonsolicitation.
For a period of two (2) years from the execution of this
Agreement, you will not (a) directly or indirectly own, manage, operate, join, control, participate
in, invest in, or otherwise be connected with, in any manner, whether as an officer, director,
employee, partner, investor or otherwise, any business entity that is engaged in any other business
in which Mymetics is engaged as of the date of this Agreement, (1) in all locations in which
Mymetics is pursuing its business plan or doing business, and (2) in all locations in respect of
which Mymetics is actively planning for and/or pursuing a business opportunity; (b) for yourself or
on behalf of any other person, partnership, corporation or entity, call on any merger partner,
investor, target company, or customer of Mymetics for the purpose of soliciting, diverting or
taking away any such merger partner, bank, investor, target company, or customer
from Mymetics (1) in all locations in which Mymetics is doing business or pursuing its
business plan, and (2) in all locations in respect of which Mymetics is actively planning for
and/or pursuing its business plan, an acquisition or other business opportunity, or (c) induce,
influence or seek to induce or influence any person engaged as an employee, representative, agent,
independent contractor or otherwise by Mymetics, to terminate his or her relationship with
Mymetics. Nothing herein contained shall be deemed to prohibit you from (x) investing your funds
in securities of an issuer if the securities of such issuer are listed for trading on a national
securities exchange or are traded in the over-the-counter market and your holdings therein
represent less than 2% of the total number of shares or principal amount of the securities of such
issuer outstanding, or (y) owning securities, regardless of amount, of Mymetics.
12.
Compliance with Older Workers Benefit Protection Act
.
The parties acknowledge and
agree that, in accordance with the Older Workers Benefit Protection Act, you
Mr. Ernst Luebke
July 30, 2010
Page 4
have been informed that you have twenty-one (21) days from the date this Agreement is
initially offered to you to consider the offer detailed in this Agreement (although Mymetics would
hope to conclude this matter as quickly as possible). In addition, you understand that you may
revoke this Agreement at any time within seven (7) days after it is signed by you. Any revocation
must be in writing and delivered to Jacques-François Martin within eight (8) days of signing this
Agreement to be effective. Any revocation should be transmitted to Jacques-François Martin,
President, Mymetics Corporation, at its address above, fax number (021) 653 2473.
Because of your right to revoke this Agreement, it
shall not become effective until the eighth (8
th
) day after it has been signed, and you
will not be paid or otherwise provided any portion of your compensation under this Agreement until
it becomes effective.
13. Indemnification.
Mymetics agrees that if you are made a party, or are threatened to be
made a party, to any action, suit or proceeding, whether civil, criminal, administrative or
investigative, including any case brought against you in any country by Dr. Pierre-Francois Serres
as a direct or indirect result of an alleged wrongful termination of him by Mymetics or any other
reason (a Proceeding), by reason of the fact that you were a shareholder, director, officer,
agent or employee of Hippocampe SA, Mymetics or any subsidiary or were serving at the request of
Hippocampe SA, Mymetics or any subsidiary as a director, officer, member, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise, including service with
respect to employee benefit plans, whether or not the basis of such Proceeding is your alleged
action in an official capacity while serving as a director, officer, member, employee or agent, you
shall be indemnified and held harmless by Mymetics to the fullest extent legally permitted or
authorized by its certificate of incorporation or bylaws or resolutions of Mymeticss certificate
of incorporation or bylaws or resolutions of its Board of Directors or, if greater, by the laws of
the
State of Delaware, against all cost, expense, liability and loss (including, without
limitation, attorneys fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or
to be paid in settlement) reasonably incurred or suffered by you in connection therewith, and such
indemnification shall continue as to you even if you have ceased to be a director, member, officer,
employee or agent of Mymetics or other entity and shall inure to the benefit of your heirs,
executors and administrators. This indemnification provision shall extend to the assistance you
provide pursuant to this Agreement.
14. Non-Admission of Liability
. By making this Agreement, you and Mymetics are not admitting
that either has committed any wrong. The parties agree that this Agreement is inadmissible as
evidence in any proceeding, legal or otherwise, except to the extent necessary to enforce its
provisions.
15. Future Cooperation.
You agree that, subsequent to the execution of this Agreement, you
will reasonably cooperate with Mymetics, its attorneys, agents, employees, and representatives in
connection with any lawsuit, charge, claim, subpoena, or investigation filed against Mymetics, to
the extent such business, lawsuit, charge, claim, subpoena, or investigation directly and
materially related to your actions (including any failure to act), conduct, duties, and/or
responsibilities during your employment with Mymetics, either as an employee, officer, or director.
You also agree you will reasonably cooperate with Mymetics in connection with any regulatory
filings in connection with your termination of employment or activities in connection with your
role as an employee, officer or director of Mymetics. Such cooperation shall be
Mr. Ernst Luebke
July 30, 2010
Page 5
without any additional compensation, except for reimbursement for reasonable expenses incurred by
you for activities authorized in advance by Mymetics.
16. Press Release.
Mymetics will draft a press release to express its appreciation for the
contributions that you have made to Mymetics to announce your resignation as CFO of Mymetics and
that will be mutually satisfactory to both parties.
17. Remedies for Breach.
You understand that Mymetics may sustain irreparable injury if you
violate Sections 8, 9 or 11 of this Agreement. In order to limit or prevent such irreparable
injury, Mymetics shall have the right to enforce this Agreement and any of the provisions of
Sections 5, 6 or 11 by injunction, specific performance or other equitable relief, without bond and
without prejudice to any other rights and remedies that Mymetics may have for a breach of this
Agreement. In addition, you understand that a material breach of this Agreement by you will result
in termination of any payments to you under this Agreement and forfeiture of any past payments made
to you under this Agreement as well as termination of any stock that has not vested under the terms
of this Agreement.
18. Severability.
If any provision of this Agreement or the application thereof, to any
extent shall be held to be invalid or unenforceable, the remainder of the Agreement may be enforced
to the fullest extent permitted by law.
19. Binding Effect.
This Agreement is binding upon the successors and assigns of you and
Mymetics. Neither party may assign or delegate its or his obligations with respect to this
Agreement without the other partys prior written consent.
20. Entire Agreement.
The understandings set forth herein represent the entire agreement of
the parties with respect to the matters contained herein. The parties have not relied upon any
other agreements, understandings or representations except to the extent specifically set further
herein. Your Employment Agreement dated July 1, 2006 between you and the Company is hereby
terminated and hereafter shall be null and void. This Agreement may not be altered or modified
except by mutual agreement of the parties, evidenced in writing and executed by both parties and
specifically identified as an amendment to this Agreement. This Agreement shall be governed by and
interpreted in accordance with the laws of the State of Delaware without regard to its conflict of
law provisions.
You represent and acknowledge that in executing this Agreement you are not relying upon any
representation or statement made by any Mymetics representative with regard to the subject matter,
basis or effect of this Agreement.
21. Review Rights.
Both parties acknowledge that they have been given an adequate opportunity
to review this Agreement, that they understand its terms and effects, that they have
consulted with counsel prior to executing this Agreement, and that they have signed this Agreement
knowingly, voluntarily and of their own free will.
Mr. Ernst Luebke
July 30, 2010
Page 6
22. Counterparts.
This Agreement may be executed in counterparts, each of which shall be
deemed an original, but all of which, when taken together, shall constitute one and the same
instrument.
By signing below, the parties signify that they have read the terms of this Agreement, fully
understand its terms, are voluntarily agreeing to those terms, and intend to be legally bound.
|
|
|
|
|
|
Sincerely,
MYMETICS CORPORATION
|
|
|
By:
|
/s/ Jacques-François Martin
|
|
|
|
Jacques-François Martin, President
|
|
|
|
|
|
|
Date:
|
August 5, 2010
|
|
|
|
|
|
|
READ AND AGREED TO
:
|
|
|
/s/ Ernst Luebke
|
|
|
Ernst Luebke
|
|
|
Date:
August 5, 2010
Exhibit A
CONSULTING AGREEMENT
Exhibit 10.2
CONSULTING AGREEMENT
This Consulting Agreement (this
Agreement
) dated August 1, 2010, is entered into by
and between Mymetics Corporation, a Delaware corporation, with its principal place of business at
Route de la Corniche 4, CH-1066 Epalinges, Switzerland (the
Company
), and Ernst Luebke,
whose principal address is 39, Route dArzier, 1273 Arzier, Switzerland (
Consultant
).
1.
Consulting Relationship
.
During the term of this Agreement, Consultant will
provide consulting services (the
Services
) to the Company as described on
Exhibit
A
attached to this Agreement. Consultant shall have the title of Senior Advisor to the
President. Consultant represents that Consultant has the qualifications, the experience and the
ability to properly perform the Services. Consultant shall use Consultants best efforts to
perform the Services such that the results are satisfactory to the Company at the Companys sole
discretion.
2.
Fees and Expenses.
As consideration for the Services to be provided by Consultant
and other obligations, the Company shall pay to Consultant the amounts specified in
Exhibit
B
attached to this Agreement at the times specified therein, and the Company shall reimburse
Consultant for all reasonable travel, entertainment and other expenses incurred or paid by
Consultant in connection with, or related to, the performance of Consultants responsibilities or
services under this Agreement, upon presentation by Consultant of documentation, expense
statements, vouchers, and such other supporting information as the Company may request, or as may
be consistent with standard Company practices in accordance with the Companys Expense Policies as
attached to this Agreement as
Exhibit C
.
3.
Term and Termination
.
Consultant shall serve as a consultant to the Company from
August 1, 2010 through December 31, 2010.
4.
Independent Contractor
.
Consultants relationship with the Company will be that of
an independent contractor and not that of an employee.
(a)
Method of Provision of Services
:
Consultant shall be solely responsible for
determining the method, details and means of performing the Services,
provided
,
however
, that Consultant shall have the use of the Companys corporate office in Nyon or
Epalinges and the office equipment, including a computer and telephone, to assist in providing the
Services, such use to be subject to guidelines determined by the Companys President. Consultant
may, at Consultants own expense, employ or engage the service of such employees or subcontractors
as Consultant deems necessary to perform the Services required by this Agreement (the
Assistants). Such Assistants are not the employees of the Company and Consultant shall be wholly
responsible for the professional performance of the Services by his Assistants such that the
results are satisfactory to the Company. Consultant shall expressly advise the Assistants of the
terms of this Agreement, and ensure that any Assistants who have access to the Confidential
Information (defined below) are bound by a non-disclosure agreement in content substantially
equivalent to the provisions hereof prior to any disclosure of the Confidential Information to such
persons.
(b)
No Authority to Bind Company
.
Neither Consultant, nor any partner, agent or
employee of Consultant, has authority to enter into contracts that bind the Company or create
obligations on the part of the Company without the prior written authorization of the Company.
(c)
No Benefits
.
Consultant acknowledges and agrees that Consultant (or Consultants
employees, if Consultant is an entity) will not be eligible for any Company employee benefits,
other than for stock options under the Companys 2009 Stock Incentive Plan and, to the extent
Consultant (or Consultants employees, if Consultant is an entity) otherwise would be eligible for
any Company employee benefits but for the express terms of this Agreement, Consultant (on behalf of
itself and its employees) hereby expressly declines to participate in such Company employee
benefits.
(d)
Social Charges; Indemnification
.
The Company will pay the social charges
associated with Consultants fees received under this Agreement. Consultant shall have full
responsibility for applicable social charges for all compensation paid by Consultant to his
partners, agents or its employees under this Agreement, and for compliance with all other
applicable labor and employment requirements with respect to Consultants self-employment, sole
proprietorship or other form of business organization, and Consultants partners, agents and
employees, including state workers compensation insurance coverage requirements and any U.S.
immigration visa requirements for U.S. partners, agents and employees. Consultant agrees to
indemnify, defend and hold the Company harmless from any liability for, or assessment of, any
claims or penalties with respect to such withholding taxes, labor or employment requirements,
including any liability for, or assessment of, social charges or withholding taxes imposed on the
Company by the relevant taxing authorities with respect to any compensation paid by Consultant to
his partners, agents or employees.
5.
Supervision of Consultants Services
.
All of the Services to be performed by
Consultant, including but not limited to the Services, will be as agreed between Consultant and the
Companys President. Consultant will be required to report to the President concerning the
Services performed under this Agreement. The nature and frequency of these reports (oral or
written) will be left to the discretion of the President.
6.
Consulting or Other Services for Competitors
.
Consultant represents and warrants
that Consultant does not presently perform or intend to perform, during the term of the Agreement,
consulting or other services for, or engage in or intend to engage in an employment relationship
with, companies whose businesses in any way involve products or services which are competitive with
the Companys products or services, or those products or services currently proposed or in
development by the Company however, Consultant decides to do so, Consultant agrees that, in advance
of accepting such work, Consultant will promptly notify the Company in writing, specifying the
organization with which Consultant proposes to consult, provide services, or become employed by and
to provide information sufficient to allow the Company to determine if such work would conflict
with the terms of this Agreement, including the terms of the Confidentiality Agreement, the
interests of the Company or further services which the Company might request of Consultant. If the
Company determines that such work conflicts with the terms of this Agreement, the Company reserves
the right to terminate this Agreement immediately.
-2-
7.
Confidentiality Agreement
.
The Consultant may be afforded access to information
regarding the business and affairs of the Company and its products during the course of the
assignment (Confidential Information), except such information which (i) is already in the
partys possession, without an obligation of confidentiality with respect thereto, prior to
disclosure under this Agreement, (ii) is or subsequently becomes part of the public domain through
no act or omission of the other party, (iii) is disclosed to the party by a third party having no
obligation of confidentiality thereto, provided the party did not have actual or constructive
notice that such information was wrongfully disclosed by such third party; or (iv) is independently
developed by the party without access to or use of the Confidential Information. Notwithstanding
the foregoing, each party shall be entitled to disclose such information: (a) to its agents,
employees and representatives who have a need to know such information, for the purpose of
performance under this Agreement and exercising the rights granted under this Agreement, or (b) to
the extent required by applicable law, or (c) during the course of or in connection with any
litigation, arbitration or other judicial proceeding based upon or in connection with the subject
matter of this Agreement. The Consultant agrees to guard this Confidential Information, to hold it
in strict confidence, and not to disclose it to others without the written permission of the
Company or until such information is otherwise publicly released by the Company. The Consultant
agrees that upon termination or completion of this Agreement, any notebook, data or information
acquired or developed by the Consultant in carrying out the terms of this Agreement will be turned
over to the Company. Except as otherwise specifically authorized by the Company in writing,
information, data and reports developed or acquired by Consultant in performance of this Agreement
and furnished to the Company (the Deliverables) shall be the exclusive property of the Company.
The Deliverables shall not be disclosed to any third party without the written consent of the
Company. The Consultant acknowledges that the breach of any of the covenants contained
in this Section 7 will result in irreparable harm and continuing damages to the Company and the
Companys business, and that the Companys remedy at law for any such breach or threatened breach
would be inadequate. Accordingly, in addition to such remedies as may be available to the Company
at law or in equity in the event of any such breach, any court of competent jurisdiction may issue
an injunction (both preliminary and permanent), without bond, enjoining and restricting the breach
or threatened breach of any such covenant, including, but not limited to, an injunction restraining
the Consultant from disclosing, in whole or in part, any Confidential Information. The Consultant
shall pay all of the Companys costs and expenses, including reasonable attorneys fees and
accountants fees, incurred in enforcing such covenants.
8.
Conflicts with this Agreement
.
Consultant represents and warrants that neither
Consultant nor any of Consultants partners, employees or agents is under any pre-existing
obligation in conflict or in any way inconsistent with the provisions of this Agreement. Consultant
represents and warrants that Consultants performance of all the terms of this Agreement will not
breach any agreement to keep in confidence proprietary information acquired by Consultant in
confidence or in trust prior to commencement of this Agreement. Consultant warrants that Consultant
has the right to disclose and/or or use all ideas, processes, techniques and other information, if
any, which Consultant has gained from third parties, and which Consultant has disclosed to the
Company or which is necessary for the performance of the Services under this Agreement, without
liability to such third parties. Notwithstanding the foregoing, Consultant agrees that Consultant
shall not bundle with or incorporate into any
-3-
deliveries provided to the Company herewith any third party products, ideas, processes, or
other techniques, without the express, written prior approval of the Company. Consultant
represents and warrants that Consultant has not granted and will not grant any rights or licenses
to any intellectual property or technology that would conflict with Consultants obligations under
this Agreement. Consultant will not knowingly infringe upon any copyright, patent, trade secret or
other property right of any former client, employer or third party in the performance of the
Services required by this Agreement.
9.
Miscellaneous
.
(a)
Amendments and Waivers
.
Any term of this Agreement may be amended or waived only
with the written consent of the parties.
(b)
Sole Agreement
.
This Agreement, including the exhibits hereto, constitutes the
sole agreement of the parties and supersedes all oral negotiations and prior writings with respect
to the subject matter hereof.
(c)
Notices
.
Any notice required or permitted by this Agreement shall be in writing
and shall be deemed sufficient upon receipt, when delivered personally or by courier, overnight
delivery service or confirmed facsimile, 48 hours after being deposited in the regular mail as
certified or registered mail (airmail if sent internationally) with postage prepaid, if such notice
is addressed to the party to be notified at such partys address or facsimile number as set forth
below, or as subsequently modified by written notice.
(d)
Choice of Law
.
The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of Switzerland, without giving effect to the principles of
conflict of laws.
(e)
Severability
.
If one or more provisions of this Agreement are held to be
unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.
In the event that the parties cannot reach a mutually agreeable and enforceable replacement for
such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of
the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of
the Agreement shall be enforceable in accordance with its terms.
(f)
Counterparts
.
This Agreement may be executed in counterparts, each of which shall
be deemed an original, but all of which together will constitute one and the same instrument.
(g)
Advice of Counsel
.
EACH PARTY ACKNOWLEDGES THAT, IN EXECUTING THIS AGREEMENT,
SUCH PARTY HAS HAD THE OPPORTUNITY TO SEEK THE ADVICE OF INDEPENDENT LEGAL COUNSEL, AND HAS READ
AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT BE
CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF.
[
Signature Page Follows
]
-4-
The parties have executed this Agreement on the respective dates set forth below.
|
|
|
|
|
|
MYMETICS CORPORATION
|
|
|
By:
|
/s/ Jacques-François Martin
|
|
|
|
Jacques-François Martin
|
|
|
|
Title:
|
President & CEO
|
|
|
|
Date:
|
August 5, 2010
|
|
|
|
CONSULTANT
|
|
|
By:
|
/s/ Ernst Luebke
|
|
|
|
Ernst Luebke
|
|
|
|
|
|
|
Date:
|
August 5, 2010
|
|
EXHIBIT A
DESCRIPTION OF CONSULTING SERVICES
The Company wishes to employ Consultant to provide assistance with financial planning and
relationships with existing shareholders, and such other matters as the President may request and
that Consultant believes he is qualified to provide.
EXHIBIT B
COMPENSATION
Monthly retainer of CHF 25,000
-2-
EXHIBIT C
MYMETICS EXPENSE POLICIES
-3-
Exhibit 99.1
MYMETICS DRAFT PRESS RELEASE
Mymetics Corporation announces new Chief Financial Officer.
EPALINGES, Switzerland, August 6, 2010
Mymetics (www.mymetics.com) Corporation (OTCBB:
MYMX), announced that Ernest Luebke, Chief Financial Officer, has advised the Board of Directors
of his decision to retire as CFO effective July 31
st
2010. Mr. Luebke will be
succeeded by Mr. Ronald Kempers MSc. as Chief Financial Officer. Mr. Kempers joined Mymetics as
Chief Operating Officer in July 2009 to support the management team with the ongoing development
and growth of the company.
I want to thank Ernest for his significant contributions over the past 13 years and his
participation in bringing the company to its current status, a multi product vaccine company with
products in Human Clinical trials said Jacques François Martin, Mymetics CEO, With the
appointment of Ronald, I have the confidence that we have the right team in place to continue to
create value and build a sustainable future for Mymetics vaccine technology.
I will miss Mymetics a great deal, but its time for me to move to a new chapter in my life, Mr.
Luebke said. I know the company will progress to the next level of success with the strong
leadership of Jacques François Martin, Ronald Kempers and Sylvain Fleury.
Mr. Luebke has been with the company as an early investor and various other capacities since 1997,
including serving as the companys CFO for the last seven years. In 2003 Mr. Luebke, Dr. Sylvain
Fleury and Mr. Christian Rochet took over the management of Mymetics, assuming the direct
responsibility for the future of the company. With limited financial resources, they were able to
achieve outstanding results for the companys preventative AIDS Vaccine, the extended life Malaria
Vaccine and the acquisition of Virosome Biologicals. Mr. Luebke will retain his seat on the Board
of Directors until 31 December 2010 and will continue to provide consulting services to the company
until that date, reporting to the President and CEO.
Mr. Kempers is a senior business leader with over 15 years of experience in international business
and financial management. Prior to joining Mymetics in 2009, Mr. Kempers lead the restructuring of
an innovative Swiss medical device company as the CEO. Prior to that, he had build a very strong
career with leading global companies like Hewlett Packard and Oracle, in various regional positions
in sales, finance and business management. Mr. Kempers has a M.Sc. in Business Administration from
the Erasmus University, Rotterdam School of Management and is an IMD Business School alumnus.
About Mymetics
Mymetics Corporation is a Swiss-based biotechnology company registered in the US (OTC BB: MYMX)
developing next-generation preventative vaccines for infectious diseases. Mymetics core technology
and expertise are the use of virosomes, lipid-based carriers containing functional viral fusion
proteins, in combination with rationally designed antigens. The companys vaccines are designed to
induce protection against early transmission and infection. Mymetics is led by an international and
experienced management team and is supported by a strong Scientific Advisory Board composed of
renowned experts. The company has established contacts with world leaders in vaccine development.
Mymetics currently has five vaccines in its pipeline: HIV-1/AIDS, Influenza, Respiratory Syncytial
Virus, Herpes Simplex Virus and Malaria. The companys HIV vaccine is entering a new
proof-of-concept
preclinical trial following unprecedented results in a first study, and is also currently in a
Phase I clinical trial in human volunteers. A Phase 1b clinical trial for its Malaria vaccine on
children in Tanzania has been successfully completed, while RSV and HSV vaccine candidates are in
the preclinical phase. The Influenza vaccine has been licensed to Solvay Pharmaceuticals (now
Abbott). For further information, please visit www.mymetics.com.
Forward looking statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking
statements, which are identified by the words believe, expect, anticipate, intend, plan
and similar expressions. The statements contained herein which are not based on historical facts
are forward-looking statements that involve known and unknown risks and uncertainties that could
significantly affect our actual results, performance or achievements in the future and,
accordingly, such actual results, performance or achievements may materially differ from those
expressed or implied in any forward-looking statements made by or on our behalf. These risks and
uncertainties include, but are not limited to, risks associated with our ability to successfully
develop and protect our intellectual property, our ability to raise additional capital to fund
future operations and compliance with applicable laws and changes in such laws and the
administration of such laws. See Mymetics most recent Form 10-K for a discussion of such risks,
uncertainties and other factors. Readers are cautioned not to place undue reliance on these
forward-looking statements which speak only as of the date the statements were made.